Latest

Dec 20, 2015
Pharmaceutical Executive
The eight trends brought on by “once-and-done” interventions that may transform thinking around healthcare marketing.
Dec 11, 2015
Three days at TEDMED has convinced Bill Drummy that a dramatic shift in your definition of what’s possible is not only re-energizing, it can also help you approach your biggest problems in ways you would have never otherwise considered.
Dec 10, 2015
Pharmaceutical Executive
Pharm Exec talks with David Dosa, a leading physician in geriatric medicine, whose famous work with a cat named Oscar in end-of-life diagnostics became the stuff of therapeutic legend.
Dec 08, 2015
Pharmaceutical Executive
Casey McDonald visits with industry and regulatory officials in Bogotá to discuss Colombia’s strategy for growing its life sciences enterprise.
Dec 08, 2015
Pharmaceutical Executive
Four years after first meeting Steve Collis, Pharm Exec catches up with the AmerisourceBergen CEO to see how he’s faring on the central question of leadership—can one man change a company?
Nov 30, 2015
In the last year European regulatory authorities sharpened their focus on gathering more data and on achieving transparency and harmonization. Erick Gaussens reviews 2015 and looks at companies’ need to respond to converging demands in 2016.
Nov 29, 2015
As vital contributors to hospital disaster preparedness, the pharma industry has a role to play in making sure medical networks have what they need to meet the unforeseen, including future disasters.
Nov 24, 2015
Hightlights of Peter Young and Brent Saunders's "fireside chat" about the Allergan CEO’s early entrepreneurial years, his career in the industry, and some of his business philosophies.
Nov 23, 2015
As tech giants, enter the life sciences industry, healthcare companies should adapt their business model and embark with these new players on a more ambitious, personalized, and preventive healthcare strategy.
Nov 13, 2015
From Pharmaceutical Technology
The Generic Pharmaceutical Association has called for policy makers to take steps to promote the development of competitive generic therapies and of biosimilars.
native1_300x100
lorem ipsum